Sign In
to Vote &
Create Storyboards.
 
Express Scripts Stock No Prescription For Gains Morningstar has a bullish opinion on ESRX as detailed in this article and calculates a fair value of $89 per share for the stock. It seems to me that Morningstar's research overlooks details in the financial footnotes or, worse, does not incorporate them into their analysis. I cannot be sure.
0
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard